PF-06462700

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06462700, covering 2022-04-27 to 2022-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia [Phase 3]